These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7913258)

  • 1. Influence of prenatally inoculated anti-host MHC monoclonals on hematopoietic (mouse to rat) xenochimerism.
    Ghyselen G; Veys E
    Transplant Proc; 1994 Jun; 26(3):1179. PubMed ID: 7913258
    [No Abstract]   [Full Text] [Related]  

  • 2. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro.
    Sugiura K; Hisha H; Ishikawa J; Adachi Y; Taketani S; Lee S; Nagahama T; Ikehara S
    Stem Cells; 2001; 19(1):46-58. PubMed ID: 11209090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.
    Gaines BA; Colson YL; Kaufman CL; Ildstad S
    Exp Hematol; 1996 Jul; 24(8):902-13. PubMed ID: 8690049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero transplantation of rat hematopoietic stem cells induces xenogeneic chimerism in mice.
    Rice HE; Hedrick MH; Flake AW
    Transplant Proc; 1994 Feb; 26(1):126-8. PubMed ID: 7906444
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-species mixed chimerism (mouse + rat----mouse): facilitated engraftment of rat stem cells with untreated rat bone marrow.
    van den Brink MR; Wren SM; French SW; Hronakes ML; Ildstad ST
    Transplant Proc; 1991 Feb; 23(1 Pt 1):807-8. PubMed ID: 1671307
    [No Abstract]   [Full Text] [Related]  

  • 6. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA; Jerabek L; Edwards CT; Weissman IL
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublethal irradiation: a nonlethal method to achieve cross-species chimerism (rat-->mouse).
    el-Ezz AY; Wren SM; Kaufman CL; Ricordi C; Haluszczak C; Ildstad ST
    Transplant Proc; 1992 Dec; 24(6):2866-7. PubMed ID: 1465976
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation versus silencing of xenoreactive neonatal and fetal rat thymocytes.
    Ghyselen G; Veys E
    Transplant Proc; 1994 Jun; 26(3):1092. PubMed ID: 8029841
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
    Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
    Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H; Takeuchi Y; Shaffer J; Sykes M
    Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed hematopoietic chimerism for preventing graft-versus-host disease in mice receiving rat bone marrow transplantation.
    Pei FY; Li CF; Tang XF
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):709-13. PubMed ID: 12865228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoidance of graft versus host disease by proper titration of cell and radiation dose in a mouse to rat xeno-chimera.
    Mohiuddin MM; Qian X; Qin Y; DiSesa VJ
    Transplant Proc; 2000 Aug; 32(5):943. PubMed ID: 10936286
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced porcine hematopoiesis in mice receiving donor-specific interleukin-3.
    Yang YG; Glaser RM; Monroy R; Swenson K; Sykes M
    Transplant Proc; 1996 Apr; 28(2):655. PubMed ID: 8623328
    [No Abstract]   [Full Text] [Related]  

  • 14. Islet destruction by the NOD mouse may be mediated by both MHC-restricted and nonrestricted mechanisms.
    Matsuo S; Mullen Y; Wicker LS; Peterson LB; Nagata M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):743-4. PubMed ID: 1990674
    [No Abstract]   [Full Text] [Related]  

  • 15. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
    Siemionow MZ; Klimczak A; Unal S
    Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation.
    Jeyarajah DR; Schmeisser FS; Kadakia RA; Thistlethwaite JR
    Transplant Proc; 1994 Jun; 26(3):1201-2. PubMed ID: 8029886
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M
    Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of the murine hemopoietic-histocompatibility system: an overview.
    Cudkowicz G; Nakamura I
    Transplant Proc; 1983 Dec; 15(4):2058-63. PubMed ID: 6369680
    [No Abstract]   [Full Text] [Related]  

  • 20. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
    Ramírez M; Rottman GA; Shultz LD; Civin CI
    Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.